These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 15992377

  • 1. Treatment of YAC128 mice and their wild-type littermates with cystamine does not lead to its accumulation in plasma or brain: implications for the treatment of Huntington disease.
    Pinto JT, Van Raamsdonk JM, Leavitt BR, Hayden MR, Jeitner TM, Thaler HT, Krasnikov BF, Cooper AJ.
    J Neurochem; 2005 Aug; 94(4):1087-101. PubMed ID: 15992377
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation.
    Fox JH, Barber DS, Singh B, Zucker B, Swindell MK, Norflus F, Buzescu R, Chopra R, Ferrante RJ, Kazantsev A, Hersch SM.
    J Neurochem; 2004 Oct; 91(2):413-22. PubMed ID: 15447674
    [Abstract] [Full Text] [Related]

  • 4. Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases.
    Gibrat C, Cicchetti F.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar 30; 35(2):380-9. PubMed ID: 21111020
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine.
    Karpuj MV, Becher MW, Springer JE, Chabas D, Youssef S, Pedotti R, Mitchell D, Steinman L.
    Nat Med; 2002 Feb 30; 8(2):143-9. PubMed ID: 11821898
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington disease.
    Van Raamsdonk JM, Pearson J, Bailey CD, Rogers DA, Johnson GV, Hayden MR, Leavitt BR.
    J Neurochem; 2005 Oct 30; 95(1):210-20. PubMed ID: 16181425
    [Abstract] [Full Text] [Related]

  • 9. Pantethine and cystamine deplete cystine from cystinotic fibroblasts via efflux of cysteamine-cysteine mixed disulfide.
    Butler JD, Zatz M.
    J Clin Invest; 1984 Aug 30; 74(2):411-6. PubMed ID: 6746900
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Measurement of sulfur-containing compounds involved in the metabolism and transport of cysteamine and cystamine. Regional differences in cerebral metabolism.
    Pinto JT, Khomenko T, Szabo S, McLaren GD, Denton TT, Krasnikov BF, Jeitner TM, Cooper AJ.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct 15; 877(28):3434-41. PubMed ID: 19523884
    [Abstract] [Full Text] [Related]

  • 12. Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase.
    Borrell-Pagès M, Canals JM, Cordelières FP, Parker JA, Pineda JR, Grange G, Bryson EA, Guillermier M, Hirsch E, Hantraye P, Cheetham ME, Néri C, Alberch J, Brouillet E, Saudou F, Humbert S.
    J Clin Invest; 2006 May 15; 116(5):1410-24. PubMed ID: 16604191
    [Abstract] [Full Text] [Related]

  • 13. The accumulation of cystamine and its metabolism to taurine in rat lung slices.
    Lewis CP, Haschek WM, Wyatt I, Cohen GM, Smith LL.
    Biochem Pharmacol; 1989 Feb 01; 38(3):481-8. PubMed ID: 2917009
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Excretion of cystamine and its conversion products from the body of irradiated and nonirradiated mice].
    Pavlova LM, Bondarev NN, Sverdlov AG, Grachev SA, Saĭkova VA.
    Vopr Med Khim; 1973 Feb 01; 19(1):22-5. PubMed ID: 4788001
    [No Abstract] [Full Text] [Related]

  • 17. The uptake and metabolism of cystamine and taurine by isolated perfused rat and rabbit lungs.
    Sharma R, Kodavanti UP, Smith LL, Mehendale HM.
    Int J Biochem Cell Biol; 1995 Jul 01; 27(7):655-64. PubMed ID: 7648421
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Post-translational disulfide modifications in cell signaling--role of inter-protein, intra-protein, S-glutathionyl, and S-cysteaminyl disulfide modifications in signal transmission.
    O'Brian CA, Chu F.
    Free Radic Res; 2005 May 01; 39(5):471-80. PubMed ID: 16036322
    [Abstract] [Full Text] [Related]

  • 20. Cellular thiol pools are responsible for sequestration of cytotoxic reactive aldehydes: central role of free cysteine and cysteamine.
    Wood PL, Khan MA, Moskal JR.
    Brain Res; 2007 Jul 16; 1158():158-63. PubMed ID: 17555724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.